The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hypomethylating agent (HMA) treatment as a bridge to allogeneic hematopoietic cell transplantation (HCT) for relapsed/refractory acute myeloid leukemia (RR-AML).
 
Michael Richard Grunwald
Stock and Other Ownership Interests - Medtronic
Honoraria - Imedex; TotalCME
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; ARIAD; Cardinal Health; Celgene; Incyte; Pfizer
Research Funding - Amgen (Inst); FORMA Therapeutics (Inst); Genentech/Roche (Inst); Incyte (Inst); Janssen (Inst)
 
Danielle Boselli
No Relationships to Disclose
 
Lauren M. Bohannon
No Relationships to Disclose
 
Michael Keith Alister Zimmerman
No Relationships to Disclose
 
Jing Ai
No Relationships to Disclose
 
Thomas Gregory Knight
No Relationships to Disclose
 
Brittany K. Ragon
No Relationships to Disclose
 
Dragos Plesca
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jigar S. Trivedi
Consulting or Advisory Role - Pharmacyclics
 
Belinda Rene Avalos
Consulting or Advisory Role - Juno Therapeutics
 
Edward Alan Copelan
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Boston Biomedical; Endocyte (Inst); immatics; Lilly; Ra Pharma (Inst)
Research Funding - Bayer (Inst); Celgene (Inst); Novocure (Inst)
 
Jonathan Michael Gerber
Research Funding - Janssen Research & Development (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No. 9,012,215; U.S. Track One Patent Application No. 15/796,201